Skip to main content
. 2023 Aug 6;9(2):101334. doi: 10.1016/j.adro.2023.101334

Table 3.

Study endpoints and results

Phase 1 Feasibility of treatment delivery >90% Met
Grade ≥3 acute toxicity <20% Met
Phase 2 Grade ≥3 acute toxicity <20% Met
Good or excellent cosmesis >85% at 2 years Not met